Adjunctive allopurinol is safe, effective, and well tolerated in inflammatory bowel disease (IBD) patients who do not respond adequately to thiopurines due to hypermethylation, a randomized trial found.
Adjunctive allopurinol is safe, effective, and well tolerated in inflammatory bowel disease (IBD) patients who do not respond adequately to thiopurines due to hypermethylation, a randomized trial found.